Newly Independent Euroapi Targets €1bn Revenues In 2022
French API ‘Powerhouse’ Was Carved Out Of Sanofi In May
Euroapi says it will keep a close eye on challenging market conditions in 2022 as it as announced its first set of financial results and forecasts after separating from Sanofi.
You may also be interested in...
Sanofi has unveiled further details of its European API company, which will be called Euroapi and will be led by Karl Rotthier as CEO.
Biocon Biologics is continuing to rack up the capital needed to close its multi-billion deal for Viatris’ global biosimilars business, with two quick equity investments from parent Biocon Limited as stipulated under its acquisition agreement.
With Teva clearing up early who will replace outgoing president and CEO Kåre Schultz, Generics Bulletin looks at five issues that await his replacement, the former Sandoz head Richard Francis.